Justice Department files civil complaint against dental device manufacturer
By Ariana Portalatin
Originally at beckersdental.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental practice owners and DSOs who purchase implants or bone-grafting materials must immediately audit their supply chain for Steiner Biotechnology products; a DOJ injunction could halt all future shipments, expose clinics to recall risk, and create liability if any affected devices remain in inventory.
Key points
- The Aug. 6 civil complaint targets Steiner Biotechnology and its CEO Greg Steiner, DDS, seeking a permanent manufacturing and sales ban after alleged FDA violations of the Federal Food, Drug, and Cosmetic Act.
- The company manufactures dental devices; any on-hand stock now carries regulatory uncertainty and possible recall exposure for practices that have implanted or stocked the products.
- Clinics relying on Steiner products for bone-graft or implant procedures face potential treatment delays and will need alternative suppliers validated for quality and clearance status.
- DSOs and multi-location owners should add this supplier to their vendor-risk matrix and document any communications or recalls to protect against future malpractice or billing disputes.
Who should care
Read the original on Becker's Dental + DSO Review
Full reporting and any paywall content live on beckersdental.com. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique